Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering ONVO announced the pricing of a public offering consisting of 6,562,500 shares of common stock (or pre-funded warrants in lieu thereof).

Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare Summit ALPHARETTA, Ga., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...

Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock CHICAGO, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. today announced the closing of its initial public offering of 1,277,778 shares of common stock, including the underwriters’...

Monopar Therapeutics Inc. Announces Full Exercise of Over-Allotment by Underwriters CHICAGO, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. today announced that the underwriters of its previously announced initial public offering of common stock have exercised in full...

Monopar Therapeutics Inc. Announces Pricing of Initial Public Offering CHICAGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. today announced that it has priced an initial public offering of 1,111,112 shares of its common stock at $8.00 per share. The...